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Abstract  
Reducing the burden of physical illness among people living with severe mental illnesses (SMI) 
is a key priority. Smoking is strongly associated with SMIs resulting in excessive smoking 
related morbidity and mortality in smokers with SMI. Smoking cessation advice and assistance 
from mental health practitioners would assist with reducing smoking and smoking-related harms 
in this group. This study examined the attitudes and practices of Australian mental health 
practitioners towards smoking cessation and tobacco harm reduction for smokers with SMI, 
including adherence to the 5As (ask, assess, advise, assist and arrange follow up) of smoking 
cessation. We surveyed 267 Australian mental health practitioners using a cross-sectional, online 
survey. Most practitioners (77.5%) asked their clients about smoking and provided health 
education (66.7 %) but fewer provided direct assistance (31.1%-39.7%). Most believed that 
tobacco harm reduction strategies are effective for reducing smoking related risks (88.4 %) and 
that abstinence from all nicotine should not be the only goal discussed with smokers with SMI 
(77.9%). Many respondents were unsure about the safety (56.9%) and efficacy (39.3%) of e-
cigarettes. Practitioners trained in smoking cessation were more likely (OR 2.9, CI 1.5-5.9) to 
help their clients to stop smoking. Community mental health practitioners (OR 0.3, CI 0.1-0.9) 
and practitioners who were current smokers (OR 0.3, CI 0.1-0.9) were less likely to adhere to 
5As of smoking cessation intervention. The results of this study emphasize the importance and 
need for providing smoking cessation training to mental health practitioners especially 
community mental health practitioners.  
Keywords: Attitude of health personnel, e-cigarettes, Harm reduction, mental disorders, 
Smoking cessation,  
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INTRODUCTION  
Reducing the burden of illness attributable to physical illness among people with severe mental 
illnesses (SMI) has been identified as a key national priority (National Mental Health 
Commission, 2014). Reducing smoking rates among this population is central to this aim. 
Research suggests that people with a SMI, such as schizophrenia, bipolar disorder and major 
depression are 3-4 times more likely to smoke compared to those without a SMI (Cooper et al., 
2012, Lawrence et al., 2009). Smokers with SMI are heavier smokers, smoke more intensely and 
are more nicotine dependent compared to their counterparts in the general population (Lawrence 
et al., 2009). Tobacco smoking, which is an established risk factor for heart disease, cancers and 
cerebrovascular diseases, contributes to the high morbidity and premature mortality among this 
population group, who experience a life expectancy 10-15 years lower than the general 
population (Lawrence et al., 2013). The disproportionately high smoking rates among people 
with SMI have been attributed to neurobiological vulnerabilities to addiction, a tendency to use 
nicotine to alleviate the symptoms of mental illness and antipsychotic drugs, experiencing socio-
economic disadvantage, low access to health services and pro-smoking attitudes of health 
practitioners (McNeill, 2001). 
Smoking cessation and harm reduction in smokers with SMI 
Research specific to smokers with SMI is limited. The available evidence suggests that many 
smokers with SMI want to quit smoking (Siru et al., 2010). Interventions that are effective for 
increasing quit success among smokers without SMI are also effective for smokers with SMI 
(Banham and Gilbody, 2010). These include nicotine replacement therapy (NRT), prescription 
medications (for example varenicline and bupropion) and psycho-social interventions (Roberts et 
al., 2016). Tobacco harm reduction (THR) options may also help to reduce smoking related harm 
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for those individuals who are unable or unwilling to quit nicotine/tobacco (Gartner and Hall, 
2015). Potential THR strategies include switching partially or completely to clean nicotine 
products such as NRT (gum, patch, spray etc.), low nitrosamine smokeless tobacco (e.g. Swedish 
snus) and nicotine vaporisers like e-cigarettes (battery operated devices which produce an 
aerosol that is inhaled by the user) (Gartner and Hall, 2015). There is some evidence that these 
options may help smokers with SMI to quit or reduce their smoking. For example, extended use 
(6 months) of NRT has been tested for maintaining smoking abstinence with some success in a 
small sample of smokers with schizophrenia (Dale Horst et al., 2005). Two studies provide some 
preliminary evidence that nicotine vaporisers can help people with SMI to quit or reduce 
smoking (O'Brien et al., 2015, Caponnetto et al., 2013). Further trials are underway (Sharma et 
al., 2016). 
Health practitioners’ delivery of smoking cessation in SMI 
Health practitioner delivered smoking cessation advice has been shown to help general 
population smokers to quit smoking (Stead et al., 2008). Smoking cessation guidelines, including 
the Royal Australian College of General Practitioner (RACGP) guidelines recommend intensive 
smoking cessation counselling, pharmacotherapy and close follow up for smoking cessation in 
people with SMI (RACGP, 2011). These guidelines recommend the 5As approach (“Ask”, 
“Assess”, “Advise”, “Assist” and “Arrange”) to addressing smoking (RACGP, 2011). The 5As 
approach is designed to help practitioners remember the essential components of the smoking 
cessation counselling pathway (RACGP, 2011). Due to their higher smoking prevalence and 
greater difficulty quitting, smokers with SMI should ideally receive more smoking cessation 
advice than general population smokers. However, research suggests they do not (Mitchell et al., 
2015). A U.S. study found less than half (41%) of smokers with SMI received all the 5As of 
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smoking cessation advice (Dixon et al., 2009). A survey of American psychiatrists reported that 
they offered quit smoking advice to smokers at only 12.5% of patient visits (Himelhoch and 
Daumit, 2003).  
Failure to provide adequate smoking cessation advice may be rooted in the beliefs that smokers 
with SMI do not want to quit smoking, that smoking is an important source of pleasure for this 
population, or that smoking is less harmful than other commonly co-occurring behaviours such 
as drug abuse and self-harm (Prochaska, 2010). Furthermore, mental health practitioners 
(practitioners who provide healthcare for people with SMI), may also lack training, sufficient 
time and confidence in their ability to deliver quit smoking interventions to smokers with SMI 
(Sheals et al., 2016). 
Health practitioners and THR 
While there have been some studies on the practices and attitudes of mental health practitioners 
to providing smoking cessation advice (Sheals et al., 2016), limited research has been carried out 
on practitioners’ and mental health consumers’ views on THR strategies (Harker and 
Cheeseman, 2016, Moysidou et al., 2016 , Pratt et al., 2016, Rooke et al., 2015). Some previous 
studies have examined Australian mental health care providers’ practices towards providing 
smoking cessation and reduction advice to people with SMI (Ashton et al., 2010, Dwyer et al., 
2009, Lawn, 2004, Wye et al., 2010) but none addressed views on THR options such as 
switching to e-cigarettes and long term NRT. Studies from the US and Europe indicate that 
health professionals may hold negative attitudes towards THR practices (Beard et al., 2012, 
Kandra et al., 2014). Despite the evidence that NRT does not increase psychiatric events nor is it 
associated with increased risk of myocardial infarction or death (Stead et al., 2012), a study of 
English stop smoking practitioners and managers, found that 16 % believed that the use of NRT 
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for more than a year is harmful to health while 7.9% did not know (Beard et al., 2012). On the 
other hand, there is a growing interest in e-cigarettes among the public as well as health 
professionals. About two-thirds of physicians responding to a survey in the USA believed that e-
cigarettes are helpful in smoking cessation and one-third reported recommending e-cigarettes to 
their patients (Kandra et al., 2014). Similarly, despite having concerns about the safety and 
health effects of e-cigarettes, one-third of Greek health practitioners recommended e-cigarettes to 
their patients as a quit smoking aid (Moysidou et al., 2016). 
In light of the rapidly changing evidence and treatments for smoking cessation, prescription 
guidelines, and resources, it is important to understand the current behaviours and attitudes of 
front line staff who regularly interact with mental health consumers. The present study aimed to 
assess the practices and attitudes of Australian mental health practitioners towards assisting their 
clients to stop smoking and their beliefs about potential THR strategies for people with SMI.  
METHODS  
Participants 
An online, cross-sectional, national survey collected data from a convenience sample of 
Australian health practitioners who have clients with SMI. 
Questionnaire 
The survey questionnaire (see online supplementary Table 1) was modelled on a similar survey 
undertaken amongst another health practitioners group (Ford et al., 2015) and incorporated 
inputs from researchers involved in smoking cessation research among people with co-
morbidities and a clinician. It consisted of 6 parts:  
Part 1:  Demographic characteristics 
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Part 2 and 3: Practices related to smoking cessation covering activities from the 5As framework 
of smoking cessation (ask, assess, advise, assist and arrange follow up). The root question in 
these parts of the questionnaire asked the participants to “Please indicate how often you perform 
the following for mental health consumers with a SMI” followed by statements such as “Ask 
new adult mental health consumers about their smoking” and “Provide printed self-help 
materials on smoking cessation (e.g. brochure)”. The response options were a five point Likert 
scale ranging from “always” to “never”. 
Part 4:  Barriers faced by the participants in delivering smoking cessation interventions to their 
clients with SMI. The participants were asked to respond to 15 statements using a five point 
Likert scales ranging from “strongly agree” to “strongly disagree”.  
Part 5:  Practitioners’ interest in smoking cessation resources. The root question was “Assuming 
each of the following resources and services were available, how likely would you be to use or 
recommend them to assist mental health consumers with SMI to quit smoking?” This was 
followed by statements such as “Refer mental health consumers to a quit smoking website for 
people with SMI”. The response scale was a five point Likert scale ranging from “very likely” to 
“very unlikely”, including an option of “don’t know” 
Part 6: Beliefs about THR. This consisted of seven statements about practitioners’ beliefs about 
THR options such as smoking reduction, long term NRT use and use of e-cigarettes for smokers 
with SMI. The response scale was a six point Likert scale ranging from “very likely” to “very 
unlikely”, including an option of “don’t know”. This paper reports findings from parts one, two, 
three and six.  
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This paper reports findings from the first, second, third and sixth part of the questionnaire (See 
supplementary table 1). Results from parts four and five will be reported elsewhere supported by 
additional qualitative inquiry. 
Procedure  
The survey was distributed via government and non-government organisations identified through 
Internet searches and authors’ professional networks (see Supplementary Table 2). This study 
was approved by the research ethics committee of the School of Public Health, The University of 
Queensland (RH04122015) and the Royal Brisbane and Women’s Hospital Human Research 
Ethics Committee (HREC/15/QRBW/603). 
The survey questionnaire was converted to an electronic format in the secure survey software 
Research Electronic Data Capture (REDCap). An email invitation which included the survey 
URL was sent to the identified organisations with a request to distribute the survey among their 
staff who work with people with SMI. Advertisements containing the URL were also placed in 
newsletters of professional bodies. Participants who clicked on the survey link were directed to 
the online participant information and consent form and were able to start the survey upon 
providing consent. At the end of the survey, participants were redirected to a web page that was 
not linked to the questionnaire, where they were offered a chance to win a travel gift voucher 
(AUD 2000) in a prize draw by submitting their contact details, in appreciation of their 
completing the survey. 
Analysis 
The data was analysed in the statistical software SPSS (version 23, Chicago IL, USA). 
Descriptive statistics (e.g. percentages and means) were used to summarize participant responses. 
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Binomial multivariable logistic regression models were used to examine predictors of adherence 
to the 5A framework of smoking cessation.  
The dependent variables for analysis were constructed by transforming data from questions two 
and three of the questionnaire (see Supplementary Tables 1, 5 and 6). These statements were 
grouped to create a score for each of the five domains of the 5A framework as described in the 
RACGP guidelines (RACGP, 2011). Points were awarded for each statement to which the 
participant answered “always” or “most of the time”. A maximum of five points was available 
for each domain, such that a participant who answered 'always' or 'most of the time' to all 
statements would receive a total score of 25 (see Supplementary Table 3).  Dependent binomial 
variables were created for all 5A domains by dichotomising the responses for each domain into 1 
(those who answered 'always' or 'most of the time' for any of the statements within the domain) 
and 0 (for those who did not answer 'always' or 'most of the time' for any of the statements within 
that domain). A composite 5A variable was created where a value of 1 was given to participants 
who answered 'always' or 'most of the time' for at least one statement in all of the 5 domains, 
indicating participants who regularly practice the full 5As framework and 0 for those who did 
not.  
Predictors used in the regression models were (See Table 1): (i) Type of health professional (ii) 
Location of practice (non-urban area compared to urban and metropolitan centres); (iii) Smoking 
status (current, daily and occasional smokers compared to non-smokers) (iv) Receipt of smoking 
cessation training  
 
RESULTS 
Participant characteristics 
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Completed surveys were obtained from 267 out of 332 clicks on the survey link (80.4%). 
Participant characteristics are listed in Table 1. The sample included allied health practitioners 
(24.7%), nurses (22.8%) community mental health practitioners (health practitioners with 
vocational training in mental health who provide services to people and family with SMI in their 
homes or community centres) (22.8%) and medical practitioners (13.9%). The majority of 
respondents worked in the public sector (69.7%) and practiced in an urban or metropolitan centre 
(61.8%). Fewer than half of the participants (40.1%) reported having received smoking cessation 
training. 
Adherence to the 5As  
Table 2 shows the proportion of practitioners who performed each of the smoking cessation 
activities always or most of the time. The majority of practitioners (77.5%) asked their clients if 
they smoke or recorded smoking status on client files/notes. Fewer than half (44.9%) advised 
their smoking clients to quit smoking. However, many (75.7%) provided education about the 
adverse effects of smoking, discussed the benefits of quitting or provided counselling on how to 
quit. Only about a third provided self-help resources (31.1%), referred to other services such as 
quitline (35.9%) or prescribed cessation pharmacotherapy (39.7%). Most (86.5 %) practiced at 
least one of the 5As, although only about a third (31.8%) regularly delivered cessation assistance 
according to all the 5A domains.  
The logistic regression analyses (see Table 3) showed community mental health practitioners 
(OR 0.3, CI 0.1-0.9) were significantly less likely to regularly practice the 5As compared to 
medical practitioners. Compared to medical practitioners, all other health practitioners were less 
likely (ORs ranged from 0.2-0.3) to follow up a client’s quit attempt or provide relapse 
prevention advice to their clients. Practitioners from non-urban areas were twice as likely (OR 
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1.9, CI 1.1-3.2) to assess smoking status of their clients. Practitioners who were current smokers 
were less likely to advise their clients to quit smoking (OR 0.3, CI 0.1-0.8) or deliver all of the 
5As regularly (OR 0.3, CI 0.1-0.9). Training was a significant predictor for practicing the four 
out of 5As. Practitioners trained for smoking cessation were 2-3 times more likely to ask, assess, 
assist and arrange follow-up for their clients who smoked. Training did not significantly predict 
advising a client to stop smoking (OR 1.6, CI 0.9-2.7) or regularly performing all the 5As (OR 
1.7, CI 0.9-2.9) for clients who smoke.  
Attitudes towards THR in consumers with SMI 
There was a high level of support for THR options for smokers with SMI (Figure 1). The 
majority of respondents (88.3%) agreed that THR strategies could benefit mental health 
consumers who are unable or unwilling to quit smoking. About 78% of respondents did not 
believe that abstinence from all forms of nicotine should be the only goal discussed with their 
clients who smoke. Most respondents (61.7%) agreed that switching completely from smoking 
cigarettes to NRT as a long term substitute can substantially reduce the risk of smoking-related 
diseases. Most respondents (74.5%) also agreed that reducing the number of cigarettes smoked 
per day can substantially reduce the risk of smoking-related diseases. When asked about their 
beliefs about the role of e-cigarettes/vaping for helping smokers with SMI to reduce their risk or 
quit smoking, many (39.3%-56.9%) were unsure of their value (neither agree nor disagree or 
don’t know). Supplementary table 4 shows that nurses were more likely to agree that cutting 
down smoking reduces smoking related risk (OR 2.8, CI 1.0-7.3) and advise their clients to 
reduce their smoking (OR 2.7, CI 1.1-6.6). Practitioners who were current smokers were more 
likely agree that switching completely to NRT (OR 2.5, CI 1.1- 5.9) or vaping (OR 2.1, CI 1.0-
4.5) as a long term substitute for cigarettes may reduce smoking-related risk. Health practitioners 
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who had received smoking cessation training had higher odds of giving smoking reduction 
advice (OR 2.0, CI 1.2-3.4) and disagreeing with the statement that vaping is too harmful to 
recommend to smokers who can’t quit or aren’t able to quit (OR 2.0, CI 1.1-3.6) (Table 4). 
 
DISCUSSION 
This study examined the current smoking cessation practices and attitudes of Australian health 
practitioners towards THR strategies for smokers with SMI. We used the 5As framework to 
determine the adequacy of smoking cessation practices by participants (RACGP, 2011). Studies 
have shown that providing assistance with advice to stop smoking, increases quit rates among 
general population smokers (Aveyard et al., 2012). Participants in our survey reported asking 
(77.5%) and assessing (59.6%) their clients for smoking more often than participants of a 
previous Australian study (26.1%) which surveyed a similar sample to ours, but in one state 
(South Australia) only (Ashton et al., 2010). Our survey was open to mental health practitioners 
in all Australian states and territories. We found that while most practitioners regularly ask about 
smoking status, few provide comprehensive smoking cessation assistance to their clients. This is 
consistent with similar studies undertaken with general and mental health practitioners which 
report that a large percentage of practitioners ask their clients about smoking status but fewer 
provide assistance to quit (Ferketich et al., 2006, Johnson et al., 2009).  
Most practitioners regularly performed at least one activity from the 5As framework, but less 
than a third performed all of them 'always' or 'most of the time'. Training in smoking cessation 
was an important predictor of regularly practicing the 5As, however fewer than 50% of 
respondents had been trained in providing smoking cessation assistance.  These results are 
similar to those reported by a metanalysis of eight studies, which assessed the effectiveness of 
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providing smoking cessation training to health care professionals on provision of quit smoking 
advice (Carson et al., 2012). Further, quit smoking advice delivered by trained professionals is 
associated with better abstinence rates than when delivered by untrained individuals (Carson et 
al., 2012). Trained practitioners in our sample were also more supportive of harm reduction 
strategies including switching to vaping and cutting down (Table 4). Increased knowledge about 
the effectiveness and safety of NRT gained during smoking cessation training may result in 
increased acceptance of approaches such as these, even if not actively addressed in the training. 
Disappointingly, fewer than half of the practitioners in our survey had received smoking 
cessation training.  
Many cessation resources are available which could increase the success rate of quit attempts by 
smokers with SMI, such as self-help materials, quit line referrals and cessation pharmacotherapy, 
however these appeared to be underutilised in our sample. Three types of cessation 
pharmacotherapy (nicotine patches, bupropion and varenicline) are publicly subsidised in 
Australia under the Pharmaceutical Benefits Scheme (PBS). Two recent systematic reviews and 
meta-analyses of clinical trials reported that bupropion and varenicline increase the odds of 
successfully quitting by 4-5 times compared to a placebo among smokers with SMI (Roberts et 
al., 2016, Wu et al., 2016). The reasons for low rates of assistance with pharmacotherapy could 
be lack of training and knowledge or authority to prescribe some smoking cessation medications 
(varenicline and bupropion). Provision of subsidized NRT for disadvantaged smokers is 
considered beneficial by staff of consumer service organisations (Bryant et al., 2010). Absence 
of such subsidies for most NRTs (except for the patch which is subsidised via PBS) may deter 
mental health practitioners from recommending them to their clients. Despite the superior 
smoking cessation efficacy of varenicline, some practitioners may be hesitant to prescribe it for 
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smokers with SMI, due to concerns about neuropsychiatric adverse events. There is evidence that 
smokers with SMI are not more likely to experience adverse events with varenicline compared to 
other stop smoking medications and general population smokers (Anthenelli et al., 2016, Wu et 
al., 2016, Roberts et al., 2016). However, as recommended by smoking cessation guidelines, 
some effects may warrant caution and close patient monitoring when prescribing these 
medications for people with SMI (RACGP, 2011). 
The prevalence of smoking among our respondents was similar to that of the general Australian 
population (Australian Government:The Department of Health, 2016). Practitioners who smoke 
were less likely to practice the 5As compared to non-smokers. This finding is similar to the 
results from a meta-analysis of 20 studies which found that smokers are less likely to give quit 
smoking advice to their patients compared to non-smokers (Duaso et al., 2014). Belief in the 
“right to smoke”, feeling like a hypocrite and fear of offending the client and affecting the 
therapeutic relationship may be barriers that decrease health practitioners’ willingness to deliver 
smoking cessation assistance if they smoke (Cancer Council NSW, 2008). For example, one 
Australian study found that the majority of Australian mental health nurses who smoked believed 
in “smoking rights" of mental health consumers (Dwyer et al., 2009). Compared to non-smokers, 
more mental health practitioners in the UK who smoked believed that addressing smoking in 
their clients would adversely affect their therapeutic relationship (Harker and Cheeseman, 2016).  
Smokers with SMI often have greater nicotine dependence and experience substantial difficulty 
in quitting (McNeill, 2001, Sharma et al., 2016). Hence, harm reduction strategies which don't 
require complete abstinence from nicotine may be particularly useful for smokers with SMI who 
are unable or unwilling to quit smoking using traditional abstinence-focussed methods (Sharma 
et al., 2016).  The majority of our respondents agreed that non-abstinence based approaches were 
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appropriate for reducing the harms caused by smoking among people with SMI. However, the 
majority (especially nurses) erroneously believed that cutting down the number of cigarettes 
smoked per day substantially reduced the risk of smoking related harms. Cutting down may be a 
useful first step toward quitting, however reducing the number of cigarettes smoked per day has 
not been found to reduce long term mortality in population based studies (Godtfredsen et al., 
2002). 
Whether smokers with SMI should be encouraged to switch to vaping to reduce their health risks 
is controversial (Sharma et al., 2016). Our questions about views on switching to vaping as a 
THR strategy elicited a high proportion of neutral or 'don't know' responses, indicating a high 
degree of uncertainty about this strategy among our respondents. However, of those who had an 
opinion, more agreed than disagreed that switching to vaping could assist smokers with SMI to 
reduce their health risk. The uncertainty about vaping may reflect the emergent and contested 
evidence-base regarding the safety and efficacy of e-cigarettes which has led to debates about 
whether health practitioners should recommend smokers switching to vaping (McNeill, 2016). 
Current Australian policies ban the sale of non-therapeutic nicotine products, such as e-cigarettes 
and nicotine containing e-liquids, with the exception of tobacco intended for smoking (Douglas 
et al., 2015). Some professional organisations, such as the Australian Medical Association, have 
issued position statements which do not recognize e-cigarettes as cessation aids (AMA, 2015). 
By contrast, public and mental health organisations in the UK such as Royal College of 
Psychiatrists and Public Health England recommend switching to vaping nicotine for smokers 
who cannot or will not quit smoking (Public Health England, 2015, RCPSYCH, 2015). 
Developing the evidence base concerning vaporised nicotine as a THR strategy, particularly for 
high priority groups, such as smokers with SMI is urgently needed.  
15 
 
Practitioners who smoked were more likely to be supportive of THR strategies such as use of 
NRT or e-cigarettes as long-term substitutes for cigarettes. One possible reason for our finding 
could be that practitioners’ lived experience of nicotine addiction might increase knowledge 
about and receptiveness to a wide range of smoking cessation interventions, including non-
abstinence strategies (Pelkonen and Kankkunen, 2001).    
Strengths and Limitations  
The respondents in this survey represented a wide range of mental health professionals, including 
nurses, social workers and community mental health practitioners. These health practitioners are 
closely involved in the routine health care of people with SMI which provides opportunities to 
deliver brief interventions. As our sample was a convenience sample obtained by widespread 
distribution of a survey invitation through relevant organisations and professional bodies (see 
supplementary Table 2), we are unable to determine a response rate or the representativeness of 
the sample. Our sample size of 267 is comparable to other similar surveys among mental health 
practitioners (Connolly et al., 2013, Dwyer et al., 2009). Our respondents may also represent 
those most interested in the topic of smoking cessation and might be more motivated to engage 
in smoking cessation activities, hence our results are likely to be conservative and over- rather 
than under-estimate the engagement of mental health practitioners in smoking cessation 
activities. 
CONCLUSION  
This study reports the findings of a national survey which assessed Australian mental health 
practitioners’ practices and attitudes towards smoking cessation and THR options such as e-
cigarettes. We found that smoking cessation training and being a non-smoker are important 
predictors of delivery of smoking cessation assistance. Nurses were more likely to endorse 
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cutting down the number of cigarettes smoked as a THR strategy, despite little evidence that this 
substantially reduces smoking related harms. The majority of respondents supported THR rather 
than only nicotine abstinence for smokers with SMI.  
RELEVANCE FOR CLINICAL PRACTICE 
Firstly, this study highlighted the ongoing challenge of mobilising mental health practitioners to 
transition from just asking/assessing smoking status to providing smoking cessation interventions 
during clinical consultations. Training mental health practitioners in smoking cessation may 
increase the delivery of comprehensive smoking cessation assistance to smokers with SMI and 
also improve the efficacy of this assistance. Secondly, responsibility for delivering smoking 
cessation assistance should be shared across all health workers who work with people with SMI. 
All practitioners including nursing and medical practitioners, community mental health workers 
as well as allied health practitioners should be given smoking cessation training. Government 
and non-government organisations may like to consider how they can provide and incentivise 
training of mental health professionals, to deliver evidence-based smoking cessation assistance to 
people with SMI (Cancer Council NSW, 2008). Thirdly, considering the high level of support for 
THR, it would be useful for these training programs to incorporate harm reduction options, such 
as long term use of NRT and accurate information on the current evidence on e-cigarettes. This 
would help them address the increasing inquiries about these products from consumers with 
SMI. Lastly, mental health practitioners who smoke should be encouraged and assisted to stop 
smoking.  
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Table 1: Participant characteristics 
 N (%) 
Type of health practitioner †  
Medical practitioners 37 (13.85) 
Nurses 61 (22.84) 
Allied health practitioners 66 (24.7) 
Community mental health practitioners 74 (22.84) 
Others 29 (3.4) 
Place of Practice ‡  
Urban and metropolitan centres 165 (61.8) 
Non-urban centres 102 (38.2) 
Health sector  
Public 186 (69.7) 
Private 81 (30.3) 
Current, daily or occasional smoker 34 (12.7) 
  
Received tobacco cessation training 107 (40.1) 
 † Respondents were grouped into the following categories depending on how they identified 
themselves: Medical practitioners: General practitioners and medical specialists; Nurses: 
Nurses and nurse practitioners; Allied health practitioners: Occupational therapist, 
psychologists, pharmacists and social workers; Community mental health practitioners: 
community mental health practitioners, mental health practitioners and peer workers   ‡ Non-
urban centres included rural, remote, small and medium centres 
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 Table 2:  Participants delivery of 5As of smoking cessation 
5A 
Domain 
Activity performed 
 
Perform 
the 
activity 
(always/
most of 
the time) 
 N (%) 
 
Perform at 
least one 
activity from 
the domain 
always/most 
of the time  
N (%) 
 
Median 
weighted 
total score 
(range) 
Ask Ask new adult mental health 
consumers about their smoking 
197 
(73.8) 
207 (77.5) 5 (0-5) 
Keep record of mental health 
consumers’ smoking status 
158 
(59.2) 
Assess Assess a mental health consumer’s 
readiness to quit smoking 
141 
(52.8) 
159 (59.6) 2.5 (0-5) 
Assess a mental health consumer’s 
level of nicotine dependence 
112 
(41.9) 
Advise Advise mental health consumers who 
smoke to quit smoking 
120 
(44.9) 
120 (44.9) 0.0 (0-5) 
Assist§ Health education 178 
(66.7) 
202 (75.7) 2.0 (0-5) 
Self-help resources 83 (31.1) 
Referral 96 (35.9) 
Counselling 131 
(49.1) 
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Pharmacotherapy (including NRT) 106 
(39.7) 
Arrange Arrange follow up 135 
(50.6) 
158 (59.2) 2.5 (0-5) 
Provide relapse prevention advice 105 
(39.3) 
Median 
5A score 
13.5(0-25) 
§ Health education included informing the clients about general risks of smoking, benefits of 
quitting and particular relevance of quitting for people with SMI. Self-help resources included 
providing self-help material like informational brochures and recommending technology 
based resources (e.g. smoking cessation mobile apps and websites). Referral included 
encouraging to call Quit line, sending a referral form to Quit line or referring to group or 
individual counselling. Counselling included providing motivational interviewing or 
discussing how to overcome barriers to quitting.  Pharmacotherapy included using RACGP 
treatment algorithm, or prescribing bupropion, varenicline or NRT. 
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Table 3: Logistic regression analyses: Associations between participant characteristics and delivery of the 5As 
 
 Perform at least one activity from the following domains always or most of the time  
 Ask Assess Advise Assist Arrange Perform at 
least one 
activity from 
each of the 5As 
 OR (95% CI) 
Type of practitioner       
Medical 
practitioner 
1.0 1.0 1.0 1.0 1.0 1.0 
Nurse 0.6 (0.1-2.3) 2.4 (0.9-5.9) 2.0 (0.8-4.9) 0.3 (0.1-1.4) 0.3 (0.1-0.9) * 1.9 (0.8-4.7) 
Allied 0.3 (0.1-1.1) 0.9 (0.4-2.1) 0.5 (0.2-1.3) 0.1 (0.03-0.6) * 0.2 (0.1-0.9) * 0.9 (0.4-2.1) 
Community mental 
health 
practitioners 
0.2 (0.1-0.7) * 0.9 (0.4-2.2) 0.3 (0.1-0.7) * 0.2 (0.03-0.7) * 0.3 (0.1-0.8) * 0.3 (0.1-0.9) * 
Others 0.3 (0.1-1.4) 1.7 (0.6-4.8) 0.6 (0.2-1.8) 0.2 (0.03-0.8) * 0.3 (0.1-0.9) * 0.9 (0.3-2.8) 
Practice located in 
non-urban centre 
1.4 (0.7-2.6) 1.9 (1.1-3.3) * 1.0 (0.6-1.7) 1.1 (0.6-2.1) 1.6 (0.9-2.8) 1.4 (0.8-2.4) 
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Current smoker 1.1 (0.5-2.8) 0.9 (0.4-1.9) 0.3 (0.1-0.8) * 0.6 (0.3-1.3) 0.7 (0.3-1.5) 0.3 (0.1-0.9) * 
Received cessation 
training 
2.2 (1.1-4.4) * 1.9 (1.1-3.2) * 1.6 (0.9-2.7) 2.9 (1.5-5.9) * 2.2 (1.2-3.8) * 1.7 (0.9-2.9) 
*statistically significant (p<0.05) 
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Table 4: Participant characteristics and support for harm reduction strategies 
 
    
 Strongly agree/ somewhat agree with the following for smokers with SMI 
Always 
/most of the 
times 
Strongly disagree/ 
somewhat disagree with 
the following for 
smokers with SMI 
 
 
Harm 
reduction 
(non-
abstinence) 
strategies 
may reduce 
risk 
Cutting 
down may 
reduce risk 
Switching 
completely 
to NRT long 
term may 
reduce risk 
Switching 
completely 
to vaping 
long-term 
may reduce 
risk 
 
Vaping may 
help in 
quitting 
 
Give advice 
to reduce 
smoking 
Vaping is 
too harmful 
to 
recommend 
 
Abstinenc
e from 
nicotine 
and 
tobacco 
should be 
the only 
goal 
discussed 
 OR(CI) 
Type of 
practitioner  
Medical 
practitioner 
1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
Nurse 
2.8 
(0.7-10.7) 
2.8 
(1.0-7.3) * 
1.1 
(0.4-2.7) 
1.2 
(0.5-2.8) 
0.8 
(0.4-1.9) 
2.7 
(1.1-6.6) * 
0.8 
(0.3-2.1) 
0.9 
(0.3-2.4) 
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Allied 
1.1 
(0.4-3.4) 
1.3 
(0.6-3.2) 
0.5 
(0.2-1.2) 
0.8 
(0.3-1.9) 
0.9 
(0.4-2.1) 
0.7 
(0.3-1.6) 
0.8 
(0.3-2.0) 
1.6 
(0.6-4.6) 
Community 
mental health 
practitioners 
1.7 
(0.4-5.5) 
1.5 
(0.6-3.8) 
0.4 
(0.2-0.9) * 
0.9 
(0.4-2.1) 
1.1 
(0.5-2.7) 
0.8 
(0.3-1.8) 
0.7 
(0.3-1.7) 
0.8 
(0.3-2.2) 
Others 
1.8 
(0.4-7.9) 
0.9 
(0.3-2.6) 
0.7 
(0.2-2.0) 
1.1 
(0.4-3.2) 
1.0 
(0.4-2.8) 
1.2 
(0.4-3.2) 
0.6 
(0.2-1.9) 
0.8 
(0.2-2.5) 
Non-urban 
areas 
1.1 
(0.5-2.3) 
0.8 
(0.5-1.5) 
1.2 
(0.7-2.0) 
0.9 
(0.5-1.6) 
1.1 
(0.6-1.8) 
0.9 
(0.5-1.6) 
0.6 
(0.4-1.2) 
0.8 
(0.4-1.5) 
Current 
smokers 
0.9 
(0.3-3.0) 
1.2 
(0.5-2.9) 
2.5 
(1.1-5.9) * 
2.1 
(1.0-4.5) * 
1.6 
(0.8-3.3) 
0.7 
(0.3-1.4) 
1.3 
(0.6-3.0) 
0.7 
(0.3-1.6) 
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Received 
smoking 
cessation 
training 
1.2 
(0.5-2.7) 
0.6 
(0.3-1.1) 
1.4 
(0.8-2.4) 
0.9 
(0.5-1.5) 
1.1 
(0.6-1.8) 
 
2.0 
(1.2-3.4) * 
 
2.0 
(1.1-3.6) * 
1.5 
(0.8-2.8) 
*statistically significant (p< 0.05) 
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Figure 1: Attitudes of mental health practitioners towards harm reduction 
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Supplementary Table 1: Survey Questionnaire 
Question 1. Respondent Characteristics  
1.1    What type of health practitioner are you?  
a.       General practitioner 
b.       medical specialist/specialist physician 
c.        Registered Nurse 
d.       Nurse Practitioner 
e.        Other (please specify) _________________________________________________ 
  
1.2    Does your current clinical workload include the management of patients who have severe mental illness? 
a.       Always   
b.       Most of the time  
c.        Sometimes  
d.       Hardly ever 
e.        Never 
  
1.3    How many patients with severe mental illness do you typically see in a 3-month period? _____  
(Rough estimate of the number of patients, not the number of appointments).  
  
1.4    Are you authorised to prescribe S100 medicines for treating mental illnesses? (Yes/No)  
  
1.5    Which state or territory do you currently practice in (choose primary location, i.e. one only);  
a.       Queensland  
b.       New South Wales 
c.        Victoria 
d.       Tasmania 
e.        South Australia 
f.        Western Australia 
g.        Australian Capital Territory  
h.       Northern Territory 
  
1.6    Your primary place of practice is best described as (chose one);  
a.       Small regional centre 
b.       Rural centre 
c.        remote centre 
d.       Medium to large regional centre 
e.        Urban/metropolitan  
  
1.7    I am employed in (tick as many as apply); 
a.       Public sector 
b.       Private sector 
  
1.8    Do you smoke tobacco? 
a.       Yes, I am currently a daily smoker  
b.       Yes, I smoke occasionally 
c.        No, I have quit 
d.       No, I have never smoked tobacco regularly          
  
  
1.9    Have you received training in providing brief interventions for smoking cessation? 
a.       Yes -> go to 1.10 
b.       No -> go to 1.11 
  
1.10Please provide details of this training (e.g. what type of training was this, who provided this, was it useful?) 
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_________________________________________ 
  
1.11What are the main reasons you haven’t received training in brief intervention for smoking cessation (tick as 
many as apply)? 
a.       Insufficient time  
b.        
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